Working to Eradicate Gynecologic Cancers

Sandra Goble, MS

Senior Manager, Biostatistics
Clovis Oncology Inc.
2525 28th Street
Boulder, CO
USA 80301

Papers:
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: interim results for ARIEL2 clinical trial